Cannae Board Authorizes To Repurchase Up To 10 Mln Shares; Stock Up

Cannae Holdings Inc. (CNNE) said that its board has authorized a three-year stock repurchase program, effective August 3, 2022, by which it may repurchase up to 10 million shares of its common stock.

In Friday regular trading, CNNE was trading at $23.22 up $0.88 or 3.92%.

The company noted that purchases may be made from time to time in the open market at prevailing prices or in privately negotiated transactions through August 3, 2025.

Cannae said, in combination with the remaining authorization under the company's previous repurchase program, it now has authority to repurchase 12.7 million shares of its common stock.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT